Tempus AI TEM Q1 2026 Earnings Beat Revenue NA EPS 013 Whats Next for DigitalAsset DAAQU at 1043 20260519 Polymarket Enters Private Market Trading with Contracts on OpenAI Anthropic Milestones Stocks Under Pressure as Crude Oil Recovery and Rising Bond Yields Rattle Markets Const Energy CEG Up 790 Is There More Room to Run 20260520 Harmonic HLIT Q1 2026 Profit Surges Past Wall Street Targets Wordles Sustained Engagement May Support New York Times Digital Strategy Can Leishen LSE Sustain Its 064 Momentum This Week 20260521 Jim Cramer Highlights Diversification Beyond AI in Monthly Portfolio Update Plus500 Reports 11 Revenue Growth in Latest Quarter Reaffirms FullYear Outlook Musk Loses OpenAI Court Battle as Jury Rules He Sued Too Late Amazon Expands AI Shopping Technology to Retailers Secures Kate Spade as Customer Corn Futures Decline at Midday Tuesday Amid Weather and Demand Concerns Sebi Bars Seven Entities for Social MediaLinked Stock Manipulation Freezes 20 Crore Gains GATX Q1 2026 Earnings EPS Beats Estimates as Railcar Leasing Demand Holds Steady JELD Q1 2026 Earnings Significant EPS Miss as Company Faces Headwinds KDP Q1 2026 Earnings EPS Beats Estimates by 375 Stock Rises Universal Display OLED Q1 2026 Earnings EPS Misses by a Wide Margin Stock Slips 1 SELLAS Life Sciences Group SLS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Progress Donald Trump JrBacked Enhanced Games Set for Las Vegas Debut What Investors Should Know Jiayin Group Q4 2024 Earnings Strong EPS Performance Amid Market Headwinds Dyne Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Advances Okeanis Eco Tankers Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions BlackLine Q1 2026 Earnings EPS Surges 21 Above Estimates Stock Edges Lower MVIS Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Absent ASTL Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Operational Adjustments ACB Q1 2026 Earnings EPS Miss Tempers Optimism After Return to Profitability ADMA Biologics Q1 2026 Earnings EPS Miss Weighs on Shares as Profitability Path Remains in Focus